Dr. Paspaliaris has worked at and consulted for a number of pharmaceutical and biotech companies globally. Due to his innovation he has been the founder and director of seven biotech companies since 2000. In early 2006, he founded Adistem, Ltd in Hong Kong. After finishing his doctorate in pharmacology/endocrinology in 1993 at St Vincent’s Institute of Medical Research at the University of Melbourne, he completed his post-doctoral fellowship at Pfizer Central Research in Connecticut. During this time he was given two scholarships from the Australian Federal Government, and the National Health and Medical research Council of Australia and two young investigators awards in osteoporosis research from the Australian and New Zealand Bone and Mineral Society, and the International Society for Bone and Mineral Research. After doing his clinical training in Greece, he worked in combat trauma medicine in Africa where he remained and performed humanitarian work. In 2008, Dr. Paspaliaris received an Appreciation Award from the American Association of Clinical Endocrinologists for his groundbreaking work on adipose-derived stem cells in Type II diabetes and two certificates of appreciation from the American Academy of Anti-Aging Medicine on his stem cell research and an investigators award from the Hellenic Thoracic Society. Dr. Paspaliaris has published over 20 papers, holds over 5 patents and given lectures in a variety of medical fields, mostly in stem cell medicine. He is currently a Faculty Member for the Master’s degree program in Clinical Pharmacology and Therapeutics at Democritus University Medical School and the University of Crete in Greece. He is a member of the World Society of Interdisciplinary Anti-aging Medicine, the Australian Military Medicine Association and Latin American Stem Cell Society, a Fellow of the Philippine Society of Stem Cell Medicine, a Diplomat of the American Board of Regenerative Medicine, a Fellow of the American Academy of Regenerative Medicine and a Fellow of the Royal Society of Medicine (UK).
Copyright © 2020 SUMMA Bio-Sciences - All Rights Reserved.